Dove, TRESemmé dry shampoos recalled due to possible carcinogen
Oct 25, 2022
The propellant used in the products appears to be the source of the elevated benzene levels.
E-noses promising for diagnosing cancer from exhaled breath
Jun 30, 2022
Electronic noses detect volatile organic compounds in exhaled breath to diagnose cancer.
Decline seen in patients undergoing surgery for colon, rectal cancer in 2020
Apr 11, 2024
Patients undergoing surgery in 2020 versus 2019 had a more advanced clinical and pathological tumor stage.
Cancer survivors face transportation barriers to accessing care
Mar 30, 2022
More transportation barriers were seen among younger survivors than their cancer-free peers, while elderly respondents faced similar transportation burden regardless of cancer history.
New cancer drugs approved faster in U.S. than Europe
Jun 14, 2022
The FDA received licensing applications sooner and had shorter review times compared with the European Medicines Agency.
Per-patient costs of metastatic prostate cancer estimated at $31,427
Dec 27, 2022
An increase in annual attributable costs was observed over time, from $28,311 in 2007-2013 to $37,055 in 2014-2017.
Plant-based diets tied to long-term health benefits
May 15, 2024
The benefits include a better cardiometabolic risk profile as well as lower mortality.
One-quarter of older advanced cancer patients taking eight or more drugs
Mar 20, 2023
Polypharmacy was tied to an increased risk for adverse treatment outcomes, such as toxicity and early treatment discontinuation.
Culturally tailored program increases colonoscopy completion
Feb 07, 2022
The overall rate of colonoscopy completion was 85% in the Hispanic population; the reasons for cancellation and no-show included cost.
2019 to 2020 saw 16.8 percent increase in U.S. death rate
Dec 22, 2021
The two leading causes of death continued to be heart disease and cancer, with COVID-19 the third leading cause of death in 2020.